M. S. A. El‐Gaby
- Organic Chemistry top 1%
- Synthesis and biological activity 67
- Synthesis and Characterization of Heterocyclic Compounds 61
- Synthesis and Biological Evaluation 39
- Synthesis of heterocyclic compounds 29
- Quinazolinone synthesis and applications 23
- Synthesis and Reactions of Organic Compounds 21
- Multicomponent Synthesis of Heterocycles 17
- Toxicology top 2%
- Metals and Alloys top 10%
- Pharmacology top 10%
-
- Phenothiazines and Benzothiazines Synthesis and Activities 13
- Co-authors
- Yousry A. AmmarMostafa M. GhorabMohamed A. SalemMohamed H. HelalA. M. Sh. El‐ShariefAhmed A. AtallaM. A. ZahranAbd El‐Aal M. Gaber
- Journals
- Scientific Reports (3 papers)Bioorganic Chemistry (3 papers)European Journal of Medicinal Chemistry (3 papers)
- Partner nations
- EgyptSaudi ArabiaIndonesia
In The Last Decade
M. S. A. El‐Gaby
124 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 84
- Organic Chemistry 2.0k
- Toxicology 77
- Metals and Alloys 23
- Pharmacology 140
- Molecular Biology 544
Countries citing papers authored by M. S. A. El‐Gaby
This map shows the geographic impact of M. S. A. El‐Gaby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. S. A. El‐Gaby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. S. A. El‐Gaby more than expected).
Fields of papers citing papers by M. S. A. El‐Gaby
This network shows the impact of papers produced by M. S. A. El‐Gaby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. S. A. El‐Gaby. The network helps show where M. S. A. El‐Gaby may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. S. A. El‐Gaby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 23 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 24 | |
| 8 | 2022 | 17 | |
| 9 | BIOLOGICAL EVALUATION OF SOME NOVEL THIAZOLE , THIAZOLO[3,2-a]PYRIDINE AND THIAZOLO[3',2':1,6]PYRIDINE RERIVATIVES CONTAINING DIPHENYL MOIETY ASANTIMICROBIAL AGENTS | 2014 | 2 |
| 10 | Utilities of cyanothioformamides in heterocyclic synthesis. A review | 2004 | 8 |
| 11 | Activated nitriles in heterocyclic chemistry: Facile synthesis and antimicrobial activity of some pyrimidine, pyrazolopyrimidine and pyrazolotriazine derivatives containing sulfonamido moiety | 2004 | 4 |
| 12 | Some reactions with ketene dithioacetals. Part III: Novel synthesis of pyrimidine, pyrazole and pyrazolo[3,4-d]pyrimidine derivatives as antimicrobial agents | 2004 | 2 |
| 13 | Novel synthesis and antimicrobial investigation of pyrazolo[1,5 -a ] pyrimidine and pyrazolotriazine containing piperidinyl sulfone moiety | 2004 | 2 |
| 14 | Synthesis of novel bisimidazolidinethione, bispyrroloimidazole, bisimidazoquinoxaline and bisthiopyranoimidazole derivatives from cyanothioformamides | 2003 | 10 |
| 15 | Biological Evaluation of Some Hitherto Unknown Bis[2-(tetrahydropyrimidine)phenoxy]alkane, Bis[2-(pyrazole)phenoxy]alkane and Bis[2-(fused pyran)phenoxy]alkane Derivatives | 2003 | 3 |
| 16 | Preparation of some hitherto unknown thiosemicarbazide, thiourea, bisthiourea, benzoazole derivatives bearing quinoxalin-2-yl moiety and evaluate their biological activity | 2003 | 6 |
| 17 | Various new types of macrocycles containing quinazolinone and tetrahydrobenzo-thienopyrimidinone rings with biological interest | 2003 | 1 |
| 18 | Synthesis of novel quinoxaline carboxylic acid derivatives for antimicrobial investigation | 2002 | 2 |
| 19 | Some reactions with quinoxaline-2,3-dicarboxylic acid anhydride : Novel synthesis of thieno[2,3-d]pyrimidines and pyrrolo [3,4-b]quinoxalines as antimicrobial agents | 2002 | 4 |
| 20 | Synthesis and effect of some new [1,2,4]triazolo[4,3-a]quinazolin-5(4H)-ones and related compounds on Ehrlich ascites carcinoma cells | 1999 | 20 |
About M. S. A. El‐Gaby
M. S. A. El‐Gaby is a scholar working on Organic Chemistry, Pharmaceutical Science, Toxicology, Metals and Alloys and Polymers and Plastics, having authored 129 papers that have together received 2.4k indexed citations. Recurring topics across this work include Synthesis and biological activity (67 papers), Synthesis and Characterization of Heterocyclic Compounds (61 papers), Synthesis and Biological Evaluation (39 papers), Synthesis of heterocyclic compounds (29 papers), Quinazolinone synthesis and applications (23 papers), Synthesis and Reactions of Organic Compounds (21 papers), Multicomponent Synthesis of Heterocycles (17 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (13 papers). The work is most often cited by research in Organic Chemistry (2.0k citations), Toxicology (77 citations), Metals and Alloys (23 citations), Pharmacology (140 citations) and Molecular Biology (544 citations). M. S. A. El‐Gaby has collaborated with scholars based in Egypt, Saudi Arabia and Indonesia. Frequent co-authors include Yousry A. Ammar, Mostafa M. Ghorab, Mohamed A. Salem, Mohamed H. Helal, A. M. Sh. El‐Sharief, Ahmed A. Atalla, M. A. Zahran, Abd El‐Aal M. Gaber, Nashwa M. Saleh and Magda M. F. Ismail. Their work appears in journals such as Scientific Reports, Bioorganic Chemistry, European Journal of Medicinal Chemistry, Molecules and Molecular Diversity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.